Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Jianlun Liu
Comparison of the Efficacy and Survival Analysis of Neoadjuvant Chemotherapy for Her-2-Positive Breast Cancer
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science
Related publications
Neoadjuvant Chemotherapy in Breast Cancer
Comparative Analysis of Different Neoadjuvant Chemotherapy Regimens for Triple-Negative Breast Cancer
Tumors of female reproductive system
Clinical Experience of Dual Targeted Blockade (Pertuzumab + Trastuzumab + Docetaxel) in Neoadjuvant Therapy of Early HER-2-Positive Breast Cancer
Effective Pharmacotherapy
Efficacy of Single Cycle Neoadjuvant Chemotherapy in Carcinoma Breast
International Journal of Surgery Science
Neoadjuvant Chemotherapy: Role in Breast Cancer
Neoadjuvant Chemotherapy of Capecitabine + Epirubicin + Cyclophosphamide Combination Therapy ( 'CEX' Therapy) for HER-2 Negative Breast Cancer, as Retrospective Study in Our Institute
Journal of Nippon Medical School
Medicine
Neoadjuvant Chemotherapy and Bevacizumab for HER2-Negative Breast Cancer
New England Journal of Medicine
Medicine
Neoadjuvant Chemotherapy for Early Breast Cancer – Author's Reply
The Lancet Oncology
Oncology
Lapatinib Plus Capecitabine in Women With HER-2-Positive Advanced Breast Cancer: Final Survival Analysis of a Phase III Randomized Trial
Oncologist
Cancer Research
Medicine
Oncology
